CY1107801T1 - Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινης - Google Patents
Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινηςInfo
- Publication number
- CY1107801T1 CY1107801T1 CY20071101470T CY071101470T CY1107801T1 CY 1107801 T1 CY1107801 T1 CY 1107801T1 CY 20071101470 T CY20071101470 T CY 20071101470T CY 071101470 T CY071101470 T CY 071101470T CY 1107801 T1 CY1107801 T1 CY 1107801T1
- Authority
- CY
- Cyprus
- Prior art keywords
- human
- polymorphisms
- oatp
- effect
- statinis
- Prior art date
Links
- 101000836291 Homo sapiens Solute carrier organic anion transporter family member 1B1 Proteins 0.000 title abstract 4
- 102100027233 Solute carrier organic anion transporter family member 1B1 Human genes 0.000 title abstract 3
- 102000054765 polymorphisms of proteins Human genes 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 3
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 abstract 2
- 229960000672 rosuvastatin Drugs 0.000 abstract 2
- 102000057538 human SLCO1B1 Human genes 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Semiconductor Lasers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317592.4A GB0317592D0 (en) | 2003-07-26 | 2003-07-26 | Method |
| EP04743565A EP1651774B1 (en) | 2003-07-26 | 2004-07-26 | Use of polymorphisms in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107801T1 true CY1107801T1 (el) | 2013-06-19 |
Family
ID=27772801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071101470T CY1107801T1 (el) | 2003-07-26 | 2007-11-14 | Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινης |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7700277B2 (https=) |
| EP (1) | EP1651774B1 (https=) |
| JP (1) | JP4166257B2 (https=) |
| AT (1) | ATE373730T1 (https=) |
| CY (1) | CY1107801T1 (https=) |
| DE (1) | DE602004009083T2 (https=) |
| DK (1) | DK1651774T3 (https=) |
| ES (1) | ES2291899T3 (https=) |
| GB (1) | GB0317592D0 (https=) |
| PL (1) | PL1651774T3 (https=) |
| PT (1) | PT1651774E (https=) |
| WO (1) | WO2005012566A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080269188A1 (en) * | 2004-07-21 | 2008-10-30 | Inserm | Oatp-C Gene C463a Polymorphism Underlies Variable Response to Statin Therapy |
| JP2011512813A (ja) * | 2008-02-29 | 2011-04-28 | アイシス イノベーション リミテッド | 診断法 |
| US9817001B2 (en) | 2008-05-27 | 2017-11-14 | Boston Heart Diagnostics Corporation | Methods for determining LDL cholesterol treatment |
| US8470541B1 (en) | 2008-09-27 | 2013-06-25 | Boston Heart Diagnostics Corporation | Methods for separation and immuno-detection of biomolecules, and apparatus related thereto |
| US8765377B2 (en) | 2011-10-13 | 2014-07-01 | Boston Heart Diagnostics Corporation | Compositions and methods for treating and preventing coronary heart disease |
| US9828624B2 (en) | 2013-07-24 | 2017-11-28 | Boston Heart Diagnostics Corporation | Driving patient compliance with therapy |
| CA2968221A1 (en) | 2014-11-17 | 2016-05-26 | Boston Heart Diagnostic Corporation | Cardiovascular disease risk assessment |
| US10572811B2 (en) | 2015-01-29 | 2020-02-25 | Splunk Inc. | Methods and systems for determining probabilities of occurrence for events and determining anomalous events |
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| CN110904215A (zh) * | 2019-12-16 | 2020-03-24 | 西安和合医学检验所有限公司 | 用于同步检测slco1b1基因的两个snp位点的基因多态性的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US32011A (en) * | 1861-04-09 | Coffee-pot | ||
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4411993A (en) * | 1981-04-29 | 1983-10-25 | Steven Gillis | Hybridoma antibody which inhibits interleukin 2 activity |
| USRE32011E (en) | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
| US4543439A (en) * | 1982-12-13 | 1985-09-24 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
| US4902614A (en) * | 1984-12-03 | 1990-02-20 | Teijin Limited | Monoclonal antibody to human protein C |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| GB8902689D0 (en) | 1989-02-07 | 1989-03-30 | Ici Plc | Assay method |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| JP4071277B2 (ja) | 1993-11-12 | 2008-04-02 | ピーエイチアールアイ・プロパティーズ・インコーポレーテッド | 核酸検出用ハイブリダイゼーションプローブ、共通ステム、方法およびキット |
| EP1141282A2 (en) | 1998-08-07 | 2001-10-10 | Axys Pharmaceuticals, Inc. | Human anion transporter genes atnov |
| US20020090622A1 (en) * | 2000-08-23 | 2002-07-11 | Monisola Adeokun | Chemical compounds |
-
2003
- 2003-07-26 GB GBGB0317592.4A patent/GB0317592D0/en not_active Ceased
-
2004
- 2004-07-26 DK DK04743565T patent/DK1651774T3/da active
- 2004-07-26 DE DE602004009083T patent/DE602004009083T2/de not_active Expired - Lifetime
- 2004-07-26 PL PL04743565T patent/PL1651774T3/pl unknown
- 2004-07-26 EP EP04743565A patent/EP1651774B1/en not_active Expired - Lifetime
- 2004-07-26 AT AT04743565T patent/ATE373730T1/de active
- 2004-07-26 US US10/566,054 patent/US7700277B2/en not_active Expired - Fee Related
- 2004-07-26 PT PT04743565T patent/PT1651774E/pt unknown
- 2004-07-26 JP JP2006521655A patent/JP4166257B2/ja not_active Expired - Fee Related
- 2004-07-26 WO PCT/GB2004/003236 patent/WO2005012566A2/en not_active Ceased
- 2004-07-26 ES ES04743565T patent/ES2291899T3/es not_active Expired - Lifetime
-
2007
- 2007-11-14 CY CY20071101470T patent/CY1107801T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1651774A2 (en) | 2006-05-03 |
| DE602004009083D1 (de) | 2007-10-31 |
| US20070031838A1 (en) | 2007-02-08 |
| DK1651774T3 (da) | 2008-01-07 |
| US7700277B2 (en) | 2010-04-20 |
| WO2005012566A2 (en) | 2005-02-10 |
| ATE373730T1 (de) | 2007-10-15 |
| JP4166257B2 (ja) | 2008-10-15 |
| EP1651774B1 (en) | 2007-09-19 |
| PT1651774E (pt) | 2007-11-16 |
| DE602004009083T2 (de) | 2008-06-19 |
| WO2005012566A3 (en) | 2005-06-16 |
| PL1651774T3 (pl) | 2007-12-31 |
| GB0317592D0 (en) | 2003-08-27 |
| ES2291899T3 (es) | 2008-03-01 |
| JP2007500005A (ja) | 2007-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107801T1 (el) | Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινης | |
| ATE348616T1 (de) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| ATE353217T1 (de) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| ATE428411T1 (de) | Hdl-verstärkende kombinationstherapie-komplexe | |
| DE60315146D1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
| DE60319158D1 (de) | Pyrazoloisoquinolinenderivaten als kinase inhibitoren | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| BRPI0411078A (pt) | ligantes de receptores de canabinóides e seus usos | |
| BR0308923A (pt) | OligÈmeros de nucleobase de iap anti-sentido e empregos destes | |
| BRPI0411617A (pt) | derivados de pirimidina como ligantes de receptores de canabinóides | |
| CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
| ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
| EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
| ATE313532T1 (de) | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen | |
| PT1206474E (pt) | Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2 | |
| CY1109741T1 (el) | Sns-595 και μεθοδοι χρησης αυτου | |
| CY1108395T1 (el) | Ουσια επαυξησης της δρασης εναντι ογκων και παραγοντας εναντι ογκων | |
| EP1570270A4 (en) | THERAPEUTIC BIOKON JUGATE | |
| ATE549024T1 (de) | Chinazolin-kaliumkanalhemmer | |
| DE602005017626D1 (de) | Antivirale verwendung von borinsäurekomplexen | |
| DE60309344D1 (de) | Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen | |
| DK1553950T3 (da) | Terapeutisk behandling | |
| BRPI0409405A (pt) | compostos 7-aza-quinazolina substituìdos | |
| IS7970A (is) | PDE4-hemlar til að meðhöndla eitlafrumuæxli | |
| DE50308230D1 (de) | Pyrazoloisoquinolinenderivaten zur inhibierung von nfkappab-induzierende kinase |